TMCnet News
Financial Calendar 2022Orphazyme A/S No. 26/2021 Copenhagen – November 19, 2021 – Orphazyme A/S (ORPHA.CO; ORPH or the “Company”), a late-stage biopharmaceutical company, today announces that the company expects to publish financial reports according to the following schedule: Deadline for submission of shareholder proposals to Annual General Meeting Annual Report 2021 Annual General Meeting 2022 Interim Report First Half 2022 The financial reports will upon their release be available at the Company's website, www.orphazyme.com, where information relating to Orphazyme's Annual General Meeting 2022 will also be available in due course prior to the meeting. For additional information, please contact: Orphazyme A/S Anders Vadsholt, Chief Financial Officer +45 2898 9055 About Orphazyme A/S Attachment |